Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma. [electronic resource]
Producer: 20120907Description: 1280-1286 p. digitalISSN:- 1569-8041
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cause of Death
- Cyclophosphamide -- adverse effects
- Disease Progression
- Doxorubicin -- adverse effects
- Female
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Neoplasm Staging
- Netherlands -- epidemiology
- Prednisone -- adverse effects
- Registries -- statistics & numerical data
- Standard of Care
- Survival Analysis
- Treatment Outcome
- Vincristine -- adverse effects
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.